BioWorld MedTech

Feb. 28, 2019

View Archived Issues

BGN's AI platform for ALS progression holds key to improving care and treatment

Stakeholders revolt over Medicare hit to ultrasound rates

Researchers plan phase III GDNF trial in Parkinson's; delivery device is key

Financings

Appointments and advancements

Product briefs

Regulatory front

Other news to note

BioWorld MedTech's Orthopedics Extra

Myoscience providing opioid alternatives with launch of Iovera Smart Tip system

Aiming to help a broader patient population and provide an alternative to opioids, Myoscience Inc., of Fremont, Calif., reported the commercial launch of the Iovera Smart Tip 309. Read More

FDA gives breakthrough designation to first potential IVD test for Alzheimer's to Fujirebio

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...